Format

Send to

Choose Destination
Nat Rev Cancer. 2010 Feb;10(2):147-56. doi: 10.1038/nrc2789. Epub 2010 Jan 15.

ABC transporters in cancer: more than just drug efflux pumps.

Author information

1
Children's Cancer Institute Australia for Medical Research, Lowry Cancer Research Centre, University of New South Wales, P.O. BOX 151, Randwick NSW 2031, Australia.

Abstract

Multidrug transporter proteins are best known for their contributions to chemoresistance through the efflux of anticancer drugs from cancer cells. However, a considerable body of evidence also points to their importance in cancer extending beyond drug transport to fundamental roles in tumour biology. Currently, much of the evidence for these additional roles is correlative and definitive studies are needed to confirm causality. We propose that delineating the precise roles of these transporters in tumorigenesis and treatment response will be important for the development of more effective targeted therapies.

Comment in

PMID:
20075923
DOI:
10.1038/nrc2789
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center